[HTML][HTML] Transplantation of ACE2-mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia

Z Leng, R Zhu, W Hou, Y Feng, Y Yang, Q Han… - Aging and …, 2020 - ncbi.nlm.nih.gov
Abstract A coronavirus (HCoV-19) has caused the novel coronavirus disease (COVID-19)
outbreak in Wuhan, China. Preventing and reversing the cytokine storm may be the key to …

[HTML][HTML] Clinical study using mesenchymal stem cells for the treatment of patients with severe COVID-19

L Tang, Y Jiang, M Zhu, L Chen, X Zhou, C Zhou… - Frontiers of …, 2020 - Springer
Abstract The Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 was identified
in December 2019. The symptoms include fever, cough, dyspnea, early symptom of sputum …

The rationale of using mesenchymal stem cells in patients with COVID-19-related acute respiratory distress syndrome: What to expect

A Can, H Coskun - Stem Cells Translational Medicine, 2020 - academic.oup.com
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-caused coronavirus
disease 2019 (COVID-19) pandemic has become a global health crisis with an extremely …

[HTML][HTML] Mesenchymal stem cell infusion shows promise for combating coronavirus (COVID-19)-induced pneumonia

AK Shetty - Aging and disease, 2020 - ncbi.nlm.nih.gov
A new study published by the journal Aging & Disease reported that intravenous
administration of clinical-grade human mesenchymal stem cells (MSCs) into patients with …

[HTML][HTML] Mesenchymal stem cell therapy for severe COVID-19

L Shi, L Wang, R Xu, C Zhang, Y Xie, K Liu… - Signal transduction and …, 2021 - nature.com
Abstract The coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has placed a global public burden on health …

[HTML][HTML] Mesenchymal stem cell treatment improves outcome of COVID-19 patients via multiple immunomodulatory mechanisms

R Zhu, T Yan, Y Feng, Y Liu, H Cao, G Peng, Y Yang… - Cell research, 2021 - nature.com
The infusion of coronavirus disease 2019 (COVID-19) patients with mesenchymal stem cells
(MSCs) potentially improves clinical symptoms, but the underlying mechanism remains …

[HTML][HTML] Mesenchymal stem cell therapy for COVID-19: present or future

A Golchin, E Seyedjafari, A Ardeshirylajimi - Stem cell reviews and reports, 2020 - Springer
Abstract “COVID-19” is the word that certainly isn't forgotten by everybody who lives in the
first half of the twenty-first century. COVID-19, as a pandemic, has led many researchers …

[HTML][HTML] Mesenchymal stem cells as a potential therapy for COVID-19

S Liu, D Peng, H Qiu, K Yang, Z Fu, L Zou - Stem cell research & therapy, 2020 - Springer
The outbreak of 2019 novel coronavirus disease (COVID-19) worldwide is becoming rapidly
a major concern. The number of severe cases has increased dramatically worldwide, while …

[HTML][HTML] Mesenchymal stem cells (MSCs) as a potential therapeutic strategy in COVID-19 patients: literature research

A Coelho, RD Alvites, MV Branquinho… - Frontiers in cell and …, 2020 - frontiersin.org
In 2019, an outbreak of an unknown coronavirus–SARS-CoV-2–responsible for COVID-19
disease, was first reported in China, and evolved into a pandemic of huge dimensions and …

[HTML][HTML] Insights into the use of mesenchymal stem cells in COVID-19 mediated acute respiratory failure

N Durand, J Mallea, AC Zubair - NPJ Regenerative medicine, 2020 - nature.com
The emergence of severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) at the
end of 2019 in Hubei province China, is now the cause of a global pandemic present in over …